MYRXライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (24 4月 2024 @ 23:57):

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc...

Stats
本日の出来高	300.00
平均出来高	1 067.00
時価総額	4.14M
EPS	$-0.110 ( 2013-05-10 )
Last Dividend	$2.86 ( 2013-02-19 )
Next Dividend	$0 ( N/A )
P/E	-0.350
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2013-01-22	Couchman Jonathan	Buy	0
2013-01-18	Henderson John T	Buy	2 500	Common Stock
2013-01-18	Henderson John T	Buy	7 500	Common Stock
2013-01-18	Henderson John T	Buy	7 500	Common Stock
2013-01-18	Henderson John T	Buy	7 500	Common Stock

INSIDER POWER
0.00
Last 67 transactions
Buy: 851 709 \| Sell: 32 578

Myrexis, Inc. 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Financial Reports:

No articles found.

Myrexis, Inc. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Myrexis, Inc. Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$2.86	2013-02-19
Last Dividend	$2.86	2013-02-19
Next Dividend	$0	N/A
Payout Date	2013-02-15
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$2.86	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-04-29)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
SBSNY	Ex Dividend Junior	2023-05-02	Annually	0.00%
FRRVY	Ex Dividend Junior	2023-08-04	Sporadic	0.00%
ADRNY	Ex Dividend Knight	2023-08-11	Annually	0.00%
YAMHF	Ex Dividend Junior	2023-12-28	Annually	0.00%
MNESP	Ex Dividend Knight	2023-08-15	Quarterly	0.00%
CNLTL	Ex Dividend Junior	2023-07-07	Quarterly	0.00%
SSEZY	Ex Dividend Knight	2023-07-27	Semi-Annually	0.00%
HKMPY	Ex Dividend Knight	2023-08-11	Semi-Annually	0.00%
ARZGY	Ex Dividend Junior	2023-05-22	Annually	0.00%
OCPNF	Ex Dividend Junior	2024-03-28	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	-9.39	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.257	1.500	-3.96	-5.95	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	16.72	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	16.35	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	15.34	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0	1.000	-3.33	-3.33	[0.2 - 0.8]
operatingProfitMarginTTM	0	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.417

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	0	1.000	-0.101	0	[1 - 100]
returnOnEquityTTM	-0.257	2.50	-2.55	-5.95	[0.1 - 1.5]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-1.397

Myrexis, Inc.

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.